pumabiotechnology.comPuma Biotechnology
pumabiotechnology.com Profile
pumabiotechnology.com is a domain
that was created on 2010-08-26,making it 14 years ago.
It has several subdomains, such as investor.pumabiotechnology.com , among others.
Description：Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development...
Keywords：Puma Biotechnology, biotechnology, nerlynx, neratinib, neratinib tablets, breast cancer, early...
Discover pumabiotechnology.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
pumabiotechnology.com Information
| HomePage size: 26.445 KB |
| Page Load Time: 0.10364 Seconds |
| Website IP Address: 50.62.187.33 |
pumabiotechnology.com Similar Website
| IMBA - Institute of Molecular Biotechnology |
| KUBiC - Exploring Biotechnology Excellence | Kathmandu University |
| EL PUMA CUSCO 3 ★ |
| Institute for Bioscience and Biotechnology Research |
| Seed Biotechnology Center |
| National Center for Biotechnology Information |
| PUMA® - About PUMA |
| Puma Biotechnology, Inc. - Investor Relations |
| Amgen | A Worldwide Pioneer in Biotechnology |
| ICBB2024 | ICBB2024 | 2024 the 14th International Conference on Biotechnology and Bioengineering (14 |
| Evolutionary Genomics and Bioinformatics Group – Dept. of Genetics & Inst. of Biotechnology, Univer |
| Biotechnology Conferences | Top Biotechnology Conferences | Biotechnology Events | Industrial Biotec |
pumabiotechnology.com PopUrls
| Puma Biotechnology https://www.pumabiotechnology.com/ |
| Puma Biotechnology https://pumabiotechnology.com/pr20201015.html |
| Puma Biotechnology https://pumabiotechnology.com/pr20200226.html |
| Puma Biotechnology https://pumabiotechnology.com/pr20181206extenet.html |
| Puma Biotechnology Reports Inducement Awards Under ... https://pumabiotechnology.com/pr20231106_Inducement_Awards.html |
| Final overall survival analysis from the randomized phase ... https://pumabiotechnology.com/pr20201209_ExteNET.html |
| Puma Biotechnology https://pumabiotechnology.com/pr20200507.html |
| Puma Biotechnology https://pumabiotechnology.com/pr20180301.html |
| Puma Biotechnology https://pumabiotechnology.com/pr20140605.html |
| Puma Biotechnology Announces FDA Clearance of IND for Alisertib in ... https://investor.pumabiotechnology.com/news-releases/news-details/2023/Puma-Biotechnology-Announces-FDA-Clearance-of-IND-for-Alisertib-in-Small-Cell-L |
| Puma Biotechnology Reports Third Quarter 2021 Financial Results https://investor.pumabiotechnology.com/news-releases/news-details/2021/Puma-Biotechnology-Reports-Third-Quarter-2021-Financial-Results/default.aspx |
| Puma Biotechnology Receives FDA Orphan Drug Designation for Alisertib ... https://investor.pumabiotechnology.com/news-releases/news-details/2023/Puma-Biotechnology-Receives-FDA-Orphan-Drug-Designation-for-Alisertib-for-the-T |
| Puma Biotechnology https://www.pumabiotechnology.com/about_overview.html |
| Puma Biotechnology Reports Third Quarter 2022 Financial Results https://investor.pumabiotechnology.com/news-releases/news-details/2022/Puma-Biotechnology-Reports-Third-Quarter-2022-Financial-Results/default.aspx |
| Puma Biotechnology https://pumabiotechnology.com/2022pr.html |
pumabiotechnology.com DNS
| A pumabiotechnology.com. 600 IN A 50.62.187.33 |
| MX pumabiotechnology.com. 1800 IN MX 10 pumabiotechnology.in.tmes.trendmicro.com. |
| NS pumabiotechnology.com. 3600 IN NS ns67.domaincontrol.com. |
| SOA pumabiotechnology.com. 3600 IN SOA ns67.domaincontrol.com. dns.jomax.net. 2024050100 28800 7200 604800 600 |
pumabiotechnology.com Httpheader
| Date: Tue, 14 May 2024 17:01:30 GMT |
| Server: Apache |
| Upgrade: h2,h2c |
| Connection: Upgrade |
| Last-Modified: Thu, 02 May 2024 21:55:24 GMT |
| ETag: "4e1b7f-5e54-6177fa90a2152" |
| Accept-Ranges: bytes |
| Content-Length: 24148 |
| Vary: Accept-Encoding |
| Content-Type: text/html |
pumabiotechnology.com Meta Info
| content="Puma Biotechnology, biotechnology, nerlynx, neratinib, neratinib tablets, breast cancer, early stage, metastatic, drug development, pb272, clinical trials, oncology, her2+, biopharmaceutical, in-licensing, cancer treatment, oncology, extended adjuvant therapy, non-small cell lung cancer, biliary cancer, ExteNET, SUMMIT, FB-10 , CONTROL, NALA, tyrosine kinase inhibitor, TBCRC-022, HER2-mutated, EGFR, EGFR exon 18, EGFR exon 18-mutant, HER-Seq, alisertib, aurora kinase A, adenosine triphosphate–competitive and reversible inhibitor of aurora kinase A, inhibitor of aurora kinase A, disruption of mitosis, apoptosis of rapidly proliferating tumor cells, apoptosis of tumor cells, breast cancer, small cell lung cancer, head and neck cancer, ovarian cancer, peripheral T cell lymphoma, acute myeloid leukemia, metastatic estrogen receptor-positive (ER-positive) HER2-negative breast cancer, triple-negative breast cancer, HER2-negative breast cancer, ER-positive breast cancer" name="keywords"/ |
| content="Puma Biotechnology" name="author"/ |
| content="text/html;charset=utf-8" http-equiv="Content-Type"/ |
pumabiotechnology.com Ip Information
| Ip Country: United States |
| Latitude: 37.751 |
| Longitude: -97.822 |
pumabiotechnology.com Html To Plain Text
body, html { margin: 0; padding: 0px 0px; } .container { display: flex; width: 100%; } .left-column { width: 100%; background-color: #f0f0f0; } .right-column { flex-grow: 1; background-color: white; text-align: right; } .close-button { background-color: #cc6600; border: none; color: white; padding: 4px 6px; text-align: center; text-decoration: none; display: inline-block; font-size: 10px; cursor: pointer; } .close-button:hover { background-color: #ff6600; } We updated our Privacy Policy on March 01, 2024. To view the updated version, click here . If you do not wish personal information about you to be used as described in the Privacy Policy, please do not access or use the website or our Services. CLOSE We updated our Privacy Policy on March 01, 2024. To view the updated version, click here . If you do not wish personal information about you to be used as described in the Privacy Policy, please do not access or use the website or our Services. CLOSE May 2, 2024 - Reports First Quarter Financial Results Read April 18, 2024 - to Host Conference Call to Discuss First Quarter 2024 Financial Results Read Mar. 20, 2024 - Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer Read Feb. 29, 2024 - Reports Fourth Quarter and Full Year 2023 Financial Results Read Feb. 22, 2024 - to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference Read Feb. 15, 2024 - to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results Read Feb. 13, 2024 - Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer Read Jan. 11, 2024 - to Present at B. Riley Securities 4 th Annual Oncology Conference Read Upcoming Events May 2, 2024 - 1Q-2024 Financial Results Conference Call More Past Events Mar. 6, 2024 - TD Cowen’s 44th Annual Health Care Conference More Feb. 29, 2024 - 4Q-2023 Financial Results Conference Call More Jan. 11, 2024 - B. Riley Securities 4th Annual Oncology Conference More Dec. 11, 2023 - Corporate Presentation More Nov. 2, 2023 - 3Q-2023 Financial Results Conference Call More Oct. 11-15, 2023 - AACR-NCI-EORTC International Conference More Annual Report Archives , Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles, CA 90024 424-248-6500 Main 424-248-6501 Fax Medical Inquiries: 1-844-MED-PUMA (1-844-633-7862), or medinfo@pumabiotechnology.com Business Development: info@pumabiotechnology.com Investor Relations: ir@pumabiotechnology.com Follow Us: © 2024 , Inc. | Privacy Policy | WA Privacy Policy | Terms of Service | Data Rights Request | Legal Notice | Site...
pumabiotechnology.com Whois
Domain Name: PUMABIOTECHNOLOGY.COM Registry Domain ID: 1612945298_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2023-05-24T18:09:59Z Creation Date: 2010-08-26T19:52:17Z Registry Expiry Date: 2024-08-26T19:52:17Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS67.DOMAINCONTROL.COM Name Server: NS68.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:43:53Z <<<